More Senior Physicians See Fewer Underserved Patients
Findings for share of Medicaid patients and minority patients
ASH: Ibrutinib-Venetoclax Beneficial for Relapsed/Refractory Lymphoma
Improvement seen in progression-free survival for patients with relapsed/refractory mantle cell lymphoma
Benign Breast Disease Linked to Increased Risk for Breast Cancer
Risks increased for breast cancer overall, invasive BC, ductal carcinoma in situ in BBD cohort versus Iowa SEER program
ASH: MRD-Directed Ibrutinib-Venetoclax Treatment Beneficial in Leukemia
Improvement in survival seen with measurable residual disease-directed ibrutinib-venetoclax versus fludarabine-cyclophosphamide-rituximab
ASH: Daratumumab Beneficial for Patients With Multiple Myeloma
Addition of daratumumab to VRd results in improved progression-free survival for transplantation-eligible patients
Study Looks at Survival in Metastatic NSCLC Treated With Immunotherapy
Survival similar among racial and ethnic groups; ECOG performance status linked to survival
Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men
Findings based on men's weight at age 18 years and cancer incidence during more than 30 years
White Women Overrepresented in Gynecologic Cancer Trials
Underrepresentation seen among Asian and Hispanic women for all cancer sites, with variance for Black women by cancer site
ChatGPT Shows Poor Performance in Answering Drug-Related Questions
Nearly three-quarters of drug-related questions received no response or incomplete, wrong answers
Small Proportion of Advanced Breast Cancers Due to Biennial Versus Annual Mammogram
BMI population attributable risk proportions highest for premenopausal and postmenopausal Blacks, postmenopausal Hispanic/Latinx
